Jennifer J. Griggs is a Professor in the Division of Hematology/Oncology in the Department of Internal Medicine at the University of Michigan. Dr. Griggs is a medical oncologist who completed a postdoctoral fellowship in health services research at the University of Rochester. Her research focuses on understanding and addressing racial and social disparities in the quality of cancer chemotherapy. Dr. Griggs also conducts research on information and support needs of cancer survivors, racial disparities in the management of cancer-related pain, patient-provider communication, patient preferences for treatment, costs of care for women with ductal carcinoma in situ (DCIS), and optimal cancer treatment in obese patients. Dr. Griggs’ research program has been funded by the National Cancer Institute, the Department of Defense, the Susan G. Komen Foundation, and the Doris Duke Charitable Foundation. Dr. Griggs is active in global health work and has organized and completed several successful mission trips to Haiti to treat women with breast cancer.
Griggs JJ, Liu Y, Sorbero ME, Jagielski CH, Maly RC. Adjuvant chemotherapy dosing in low-income women: the impact of Hispanic ethnicity and patient self-efficacy. Breast Cancer Res Treat 2014; 144(3):665-72
Haymart MR, Banerjee M, Yin H, Worden F, Griggs JJ. Marginal treatment benefit in anaplastic thyroid cancer. Cancer 2013; 119(17):3133-9
Griggs JJ, Hawley ST, Graff JJ, Hamilton AS, Jagsi R, Janz NK, Mujahid MS, Friese CR, Salem B, Abrahamse PH, Katz SJ. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. J Clin Oncol 2012; 30(25):3058-64
Pini TM, Hawley ST, Li Y, Katz SJ, Griggs JJ. The influence of non-clinical patient factors on medical oncologists’ decisions to recommend breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 2012; 134(2):867-74